Patents Assigned to ARTIVILA BIOPHARMA
  • Publication number: 20240368168
    Abstract: The present invention provides an application of an SARM1 enzyme activity inhibitor in the treatment of neurodegenerative diseases or neurological diseases or conditions. The present invention particularly provides a compound of formula I as an SARM1 enzyme activity inhibitor and a pharmaceutical composition thereof.
    Type: Application
    Filed: August 25, 2022
    Publication date: November 7, 2024
    Applicant: ARTIVILA BIOPHARMA
    Inventors: Deqiang NIU, Zhendong ZHU, Ming FAN, Xuke LI
  • Publication number: 20230414581
    Abstract: Provided in the present disclosure is the use of an SARM1 enzyme activity inhibitor in the treatment of neurodegenerative diseases or neurological diseases or conditions, and in particular, provided in the present invention are a compound represented by formula (a) as an SARM1 enzyme activity inhibitor, and a pharmaceutical composition thereof.
    Type: Application
    Filed: November 9, 2021
    Publication date: December 28, 2023
    Applicant: ARTIVILA BIOPHARMA
    Inventors: Deqiang NIU, Zhendong ZHU, Yongjuan ZHAO, Wanhua LI
  • Patent number: 11325942
    Abstract: Useful chiral specific boron-containing compounds, such as boronate, boronate esters, boranamines, borane diamines, boranamine thioesters, and boronic mono/di-thioesters, have been prepared. These compounds and compositions containing them are useful as anti-cancer or anti-amyloidosis agents.
    Type: Grant
    Filed: December 30, 2020
    Date of Patent: May 10, 2022
    Assignee: BEIJING ARTIVILA BIOPHARMA CO. LTD.
    Inventor: Guoxia Han